Eyal Dayan

Eyal Dayan serves as the Vice President of Research and Development and Head of R&D Business Operations at Dexcel Pharma since July 2018. Prior to this role, Eyal Dayan was employed at Teva Pharmaceuticals from January 2012 to June 2018 as the Head of R&D Operations for IL Generic R&D and Manager of innovative drug launches. Eyal Dayan also lectured at Ben Gurion University between October 2007 and March 2012, focusing on operations research, project management, and manufacturing process management, and previously served as a teaching assistant in the industrial and management engineering department. Early career experience includes a position in the EMS department at Intel Corporation from June 2006 to October 2007. Eyal Dayan holds an M.Sc in artificial intelligence and game theory and a B.Sc in industrial engineering and management from Ben-Gurion University of the Negev.